Ir a Industrias

Salud

Asesoramiento crítico en su proceso

Con una tecnología nueva y disruptiva que desafía constantemente el statu quo, el sector de la salud avanza a pasos agigantados. Pero en un sector basado en la normativa, las asociaciones estratégicas suelen ser la clave para desarrollar con éxito los negocios. Nuestros asesores, respaldados por equipos subsectoriales en todo el mundo, utilizan su profunda experiencia en fusiones y adquisiciones, capital de crecimiento y ECM, asesoramiento en materia de deuda y servicios de financiación empresarial para encontrar su ventaja competitiva, navegar por las culturas locales y ayudarle a crear la estrategia más adecuada.

Contactar un Advisor
EN TODO EL MUNDO
556
transacciones exitosas en Salud
EN TODO EL MUNDO
Explore todas nuestras transacciones en la industria
Ir a las Transacciones
Röntgeninstitut Aarau has been acquired by Evidia
Salud

Röntgeninstitut Aarau has been acquired by Evidia

The owners of Röntgeninstitut Aarau have sold the business to Evidia Group as part of their succession planning. The former owners will remain involved in the institute and support its future development alongside Evidia.

Ver más
Olyos Group has acquired a controlling stake in NewScience
Salud

Olyos Group has acquired a controlling stake in NewScience

Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.

Ver más
Banook, backed by Motion Equity, has acquired Fluidda
Salud | TMT

Banook, backed by Motion Equity, has acquired Fluidda

Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.

Ver más
“Engaging Oaklins noticeably accelerated and advanced our succession process. The team managed it consistently and proactively and ensured that we had several attractive options available until the very end. This resulted in an outcome that exceeded our expectations.”

Dr. Herbert Wegmüller and Dr. Thierry Littmann

Owners, Röntgeninstitut Aarau

Seguir leyendo
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AR&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Delve into the latest TMT M&A: global trends, AI incidents and impact, and the road ahead

TMT SPOT ON: In-house regional and market specialists cast their eyes over meaningful trends, headline transactions and significant deal strategies within TMT.

Ver más

Contáctenos

Alejandro Dillon

Partner
Buenos Aires, Argentina
Oaklins VALO Columbus